Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis
Daniel Edmonston(Duke University), Myles Wolf(Harvard University), Steven M. Brunelli(DaVita Clinical Research (United States)), Laura M. Dember(Harvard University), Hrishikesh Chakraborty(RTI International), Srinivasan Beddhu(University of Utah), Tamara Isakova(Northwestern University), Amy Young(DaVita Clinical Research (United States)), Rebecca Brosch(DaVita Clinical Research (United States))
Cited by 46
Related Papers
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
|The Lancet|2010|1.5k
Vitamin D levels and early mortality among incident hemodialysis patients
|Kidney International|2007|791
Activated Injectable Vitamin D and Hemodialysis Survival
|Journal of the American Society of Nephrology|2005|784
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615
Newborn-Care Training and Perinatal Mortality in Developing Countries
|New England Journal of Medicine|2010|423